Immunological complications of blood transfusion

Transfusion Alternatives in Transfusion Medicine

Volumn 10, Issue 3, 2008, Pages 112-126

  Taylor, Clare ^a,b   Navarrete, Cristina ^b   Contreras, Marcela ^c  

^a SHOT Medical Director   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Antibody; Hemolytic; Immunological; Reactions; TRALI; Transfusion

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; HEPARIN; HLA ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LEUKOCYTE ANTIBODY; LEUKOCYTE ANTIGEN; OKT 3; OXYGEN; PREDNISOLONE; STEROID; THYMOCYTE ANTIBODY;

ALLERGIC REACTION; ANAPHYLAXIS; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION REACTION; CHILL; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; EXCHANGE BLOOD TRANSFUSION; FEVER; HEMOLYSIS; HUMAN; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LEUKAPHERESIS; OXYGEN THERAPY; PATHOPHYSIOLOGY; POSTTRANSFUSION PURPURA; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PROGNOSIS; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE; TRANSFUSION RELATED ACUTE LUNG INJURY; URTICARIA;

EID: 65249127554     PISSN: 12959022     EISSN: 1778428X     Source Type: Journal    
DOI: 10.1111/j.1778-428X.2008.00116.x     Document Type: Article

References (47)

1. Taylor C, Jones H, Davies T, et al. SHOT Annual Report 2007. Available at: http://www.shotuk.org
2. Stainsby D, Jones H, Asher D, et al. Serious hazards of transfusion: A decade of hemovigilance in the UK. Transfus Med Rev 2006; 20: 273-82.
3. Sazama K. Reports of 355 transfusion-associated deaths: 1976-1985. Transfusion 1990; 30: 583-90.
4. Schmidt PJ. The mortality from incompatible transfusion. In: Sandler SG, Nussbacher J, Schanfield MS (eds). Immunobiology of the Erythrocyte. Alan R. Liss, Inc.: New York, 1980, pp. 251-61.
5. Walker RH. Noninfectious risks and new trends in transfusion practice. J Fla Med Assoc 1993; 80: 37-8.
6. Ness PM, Shirey RS, Thoman SK, Buck SA. The differentiation of delayed serologic and delayed hemolytic transfusion reactions: Incidence, long-term serologic findings, and clinical significance. Transfusion 1990; 30: 688-93.
7. Mollison PL, Engelfriet CP, Contreras M. Blood Transfusion in Clinical Medicine, 10th edn. Blackwell Science: Oxford, 1997.
8. Salama A, Mueller-Eckhardt C. Delayed hemolytic transfusion reactions. Evidence for complement activation involving allogeneic and autologous red cells. Transfusion 1984; 24: 188-93.
9. Vengelen-Tyler V. Technical Manual, 12th edn. American Association of Blood Banks: Bethesda, MD, 1996.
10. Kohan AI, Niborski RC, Rey JA, et al. High-dose intravenous immunoglobulin in non-ABO transfusion incompatibility. Vox Sang 1994; 67: 195-8.
11. Linden JV, Paul B, Dressler KP. A report of 104 transfusion errors in New York State. Transfusion 1992; 32: 601-6.
12. National Patient Safety Agency. Right Patient - Right Blood. 2006. Available at: http://npsa.nhs.uk
13. Murphy M, Pamphilon DH. Practical Transfusion Medicine. Blackwell Publishing: Oxford, 2005.
14. Heddle NM, Klama LN, Griffith L, et al. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 1993; 33: 794-7.
15. Payne R. The association of febrile transfusion reactions with leuko-agglutinins. Vox Sang 1957; 2: 233-41.
16. Dzik WH. Is the febrile response to transfusion due to donor or recipient cytokine? Transfusion 1992; 32: 594.
17. Brubaker DB. Clinical significance of white cell antibodies in febrile nonhemolytic transfusion reactions. Transfusion 1990; 30: 733-7.
18. Heddle NM, Klama L, Singer J, et al. Febrile nonhemolytic transfusion reactions to platelets. Curr Opin Hematol 1995; 2: 478-83.
19. Heddle N, Tan M, Klama L, Shroeder J. Factors affecting cytokine production in platelet concentrates. Transfusion 1994; 34(Suppl.): 675 (abstract).
20. Shimizu T, Uchigiri C, Mizuno S, Kamiya T, Kokubo Y. Adsorption of anaphylatoxins and platelet-specific proteins by filtration of platelet concentrates with a polyester leukocyte reduction filter. Vox Sang 1994; 66: 161-5.
21. Greenberger PA. Plasma anaphylaxis and immediate type reactions. In: Rossi EC, Simon TL, Moss GS, Gould SA (eds). Principles of Transfusion Medicine, 2nd edn. Williams & Wilkins: Baltimore, 1996, pp. 765-71.
22. Sandler SG, Mallory D, Malamut D, Eckrich R. IgA anaphylactic transfusion reactions. Transfus Med Rev 1995; 9: 1-8.
23. Popovsky MA, Chaplin HC Jr, Moore SB. Transfusion-related acute lung injury: A neglected, serious complication of hemotherapy. Transfusion 1992; 32: 589-92.
24. Chapman CE, Stainsby D, Jones H, et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the UK, and the impact of preferential use of male donor plasma. Transfusion 2008; in press.
25. Win N, Massey E, Lucas G, et al. Ninety-six suspected transfusion related acute lung injury cases: Investigation findings and clinical outcome. Hematology 2007; 12: 461-9.
26. Yomtovian R, Kline W, Press C, et al. Severe pulmonary hypersensitivity associated with passive transfusion of a neutrophil-specific antibody. Lancet 1984; 1: 244-6.
27. Levy GJ, Shabot MM, Hart ME, Mya WW, Goldfinger D. Transfusion-associated noncardiogenic pulmonary edema. Report of a case and a warning regarding treatment. Transfusion 1986; 26: 278-81.
28. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 2005; 105: 2266-73.
29. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324: 667-74.
30. Shivdasani RA, Anderson KC. Transfusion-associated graft-versus-host disease: Scratching the surface. Transfusion 1993; 33: 696-7.
31. Ohto H, Anderson KC. Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients. Transfus Med Rev 1996; 10: 31-43.
32. Shivdasani RA, Haluska FG, Dock NL, et al. Brief report: graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors. N Engl J Med 1993; 328: 766-70.
33. Kunstmann E, Bocker T, Roewer L, et al. Diagnosis of transfusion-associated graft-versus-host disease by genetic fingerprinting and polymerase chain reaction. Transfusion 1992; 32: 766-70.
34. Wang L, Juji T, Tokunaga K, et al. Brief report: Polymorphic microsatellite markers for the diagnosis of graft-versus-host disease. N Engl J Med 1994; 330: 398-401.
35. Sage D, Stanworth S, Turner D, Navarrete C. Diagnosis of transfusion-associated graft-vs.-host disease: The importance of short tandem repeat analysis. Transfus Med 2005; 15: 481-5.
36. Klein H. Standards for Blood Banks and Transfusion Services, 17th edn. American Association of Blood Banks: Bethesda, MD, 1996.
37. BCSH Blood Transfusion Task Force. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. Transfus Med 1996; 6: 261-71.
38. Williamson LM, Stainsby D, Jones H, et al. The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease. Transfusion 2007; 47: 1455-67.
39. von dem Borne AE, van der Plas-van Dalen CM. Further observation on post-transfusion purpura (PTP). Br J Haematol 1985; 61: 374-5.
40. Gerstner JB, Smith MJ, Davis KD, Cimo PL, Aster RH. Posttransfusion purpura: Therapeutic failure of PlAl-negative platelet transfusion. Am J Hematol 1979; 6: 71-5.
41. Win N, Peterkin MA, Watson WH. The therapeutic value of HPA-1a-negative platelet transfusion in post-transfusion purpura complicated by life-threatening haemorrhage. Vox Sang 1995; 69: 138-9.
42. Shulman NR, Aster RH, Leitner A, Hiller MC. Immunoreactions involving platelets. V. Post-transfusion purpura due to a complement-fixing antibody against a genetically controlled platelet antigen. A proposed mechanism for thrombocytopenia and its relevance in 'autoimmunity'. J Clin Invest 1961; 40: 1597-620.
43. Kickler TS, Ness PM, Herman JH, Bell WR. Studies on the pathophysiology of posttransfusion purpura. Blood 1986; 68: 347-50.
44. Christie DJ, Pulkrabek S, Putnam JL, Slatkoff ML, Pischel KD. Posttransfusion purpura due to an alloantibody reactive with glycoprotein Ia/IIa (anti-HPA-5b). Blood 1991; 77: 2785-9.
45. Weisberg LJ, Linker CA. Prednisone therapy of post-transfusion purpura. Ann Intern Med 1984; 100: 76-7.
46. Cimo PL, Aster RH. Post-transfusion purpura: Successful treatment by exchange transfusion. N Engl J Med 1972; 287: 290-2.
47. Becker T, Panzer S, Maas D, et al. High-dose intravenous immunoglobulin for post-transfusion purpura. Br J Haematol 1985; 61: 149-55.